mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.
about
Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate CancerLinking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancerMicrosomal prostaglandin E2 synthase-1 inhibitors: a patent review.PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells.Regulation of mPGES-1 composition and cell growth via the MAPK signaling pathway in jurkat cells
P2860
mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
mPGES-1 in prostate cancer con ...... receptor-driven oncogenicity.
@ast
mPGES-1 in prostate cancer con ...... receptor-driven oncogenicity.
@en
type
label
mPGES-1 in prostate cancer con ...... receptor-driven oncogenicity.
@ast
mPGES-1 in prostate cancer con ...... receptor-driven oncogenicity.
@en
prefLabel
mPGES-1 in prostate cancer con ...... receptor-driven oncogenicity.
@ast
mPGES-1 in prostate cancer con ...... receptor-driven oncogenicity.
@en
P2093
P2860
P50
P356
P1476
mPGES-1 in prostate cancer con ...... receptor-driven oncogenicity.
@en
P2093
Antonio Giachetti
Donata Villari
Hiromi Hanaka
Marina Ziche
Olof Radmark
Raffaella Santi
P2860
P304
P356
10.1530/ERC-15-0277
P577
2015-06-25T00:00:00Z